semaglutide support Lack of for people on weight loss drugs leaves them vulnerable to nutritional deficiencies, say experts How to support your patients

doi: 10.1042/BCJ20160510 93

Health Canada typically reviews medications 6 to 12 months after FDA approval, meaning Canadian access could lag US availability by up to a year

Be honest about your struggles with weight loss (including past diet and exercise attempts), your health concerns related to weight (such as diabetes, hypertension, or joint pain), and your goals, whether its improved overall health, increased energy, or sustainable weight loss

Table 3 Secondary outcomes of patients with a diagnosis of T2DM receiving SGLT2is versus GLP1-RAs Values are presented as the number of events per 1,000 person-years (95% confidence interval)

As with any research compound, careful protocol design, observation, and adherence to ethical guidelines are paramount